COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
Yu‐Wei Chen, Matthew D. Tucker, Kathryn E. Beckermann, Wade T. Iams, Brian I. Rini, Douglas B. Johnson
Topics & Concepts
MedicineAdverse effectCancerVaccinationPandemicImmune systemCoronavirus disease 2019 (COVID-19)AuthorizationClinical trialFood and drug administrationInternal medicineDiseaseOncologyIntensive care medicineImmunologyPharmacologyInfectious disease (medical specialty)Computer securityComputer scienceCOVID-19 and healthcare impactsCancer Immunotherapy and BiomarkersEconomic and Financial Impacts of Cancer